首页 | 本学科首页   官方微博 | 高级检索  
     

高渗盐水预处理可减轻中性粒细胞介导的肝脏缺血再灌注损伤
引用本文:柯庆宏,郑树森,梁廷波,谢海洋,夏伟良. 高渗盐水预处理可减轻中性粒细胞介导的肝脏缺血再灌注损伤[J]. 中国病理生理杂志, 2007, 23(7): 1326-1330. DOI: 1000-4718
作者姓名:柯庆宏  郑树森  梁廷波  谢海洋  夏伟良
作者单位:浙江大学医学院附属第一医院肝胆胰外科,卫生部多器官联合移植研究重点实验室,浙江 杭州 310003
摘    要:目的:探讨高渗盐水预处理对肝脏缺血再灌注损伤的拮抗作用及其机制。方法:建立大鼠局部肝脏缺血再灌注模型。设假手术组(sham组)、缺血再灌注组(IR组)和高渗盐水预处理组(HTS组),分别于再灌注后1 h、3 h、6 h、12 h和24 h处死大鼠,测定谷丙转氨酶(ALT);抗凝血流式细胞仪测定中性粒细胞CD11b/CD18(Mac-1)的阳性率;RT-PCR和Western blotting分别测定肝内细胞间黏附分子1(ICAM-1)的mRNA和蛋白表达;比色法测定肝脏内髓过氧化物酶(MPO)活性;常规病理及电镜观察肝脏的病理学改变及肝脏内中性粒细胞的浸润情况。结果: ① HTS组在3 h、6 h和12 h血清ALT水平明显低于IR组(P<0.05)。②HTS组在6 h和12 h中性粒细胞Mac-1表达显著弱于IR组(P<0.05)。③HTS组肝脏MPO活性在再灌注后6 h、12 h和24 h明显低于IR组(P<0.05)。④HTS组大鼠肝脏内ICAM-1mRNA及蛋白表达明显低于IR组。⑤HTS组肝内中性粒细胞浸润、肝细胞浊肿和肝窦狭窄程度轻于IR组。结论: HTS预处理能够通过抑制中性粒细胞Mac-1和肝内ICAM-1的表达,明显抑制肝内中性粒细胞的黏附和聚集,起到拮抗肝脏缺血再灌注损伤的作用。

关 键 词:盐水  高渗    再灌注损伤  中性白细胞  CD11b/CD18  胞间黏附分子1  
文章编号:1000-4718(2007)07-1326-05
收稿时间:2005-09-22
修稿时间:2005-09-222005-12-28

Pretreatment of hypertonic saline attenuates the hepatic ischemia reperfusion injury induced by neutrophils
KE Qing-hong,ZHENG Shu-sen,LIANG Ting-bo,XIE Hai-yang,XIA Wei-liang. Pretreatment of hypertonic saline attenuates the hepatic ischemia reperfusion injury induced by neutrophils[J]. Chinese Journal of Pathophysiology, 2007, 23(7): 1326-1330. DOI: 1000-4718
Authors:KE Qing-hong  ZHENG Shu-sen  LIANG Ting-bo  XIE Hai-yang  XIA Wei-liang
Affiliation:Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, College of Medicine,Key Laboratory of Combined Muti-organ Transplantation, Ministry of Health, Zhejiang University, Hangzhou 310003, China. E-mail: keqinghong@zju.edu.cn
Abstract:AIM: To explore the effect of the pretreatment of hypertonic saline (HTS) in hepatic ischemia reperfusion (I/R) injury.METHODS: The rats were divided into sham group (sham group), ischemia reperfusion group (IR group) and pretreatment of hypertonic saline group (HTS group). Partial hepatic ischemia reperfusion model was used. The rats were sacrificed at the time of 1 h, 3 h, 6 h, 12 h and 24 h after reperfusion in each group, respectively. Blood samples were obtained to examine ALT. The expression of the CD11b/CD18 (Mac-1) on the neutrophils was analyzed by flow cytometry. RT-PCR and Western blotting were used to examine the expression of intercellular adhesion molecule-1 (ICAM-1) in livers and chromatometry was performed to detect the activity of myeloperoxidase (MPO) in livers. The morphology of hepatocytes and the structure of sinusoid were observed by histological examinations. RESULTS: ① HTS pretreatment decreased the level of ALT at the time points of 3 h, 6 h and 12 h after reperfusion (P<0.05). ② Mac-1 expression in HTS group was lower at 6 h and 12 h after reperfusion compared with IR group (P<0.05). ③ MPO activity in HTS group was lower at 6 h, 12 h and 24 h compared with IR group (P<0.05). ④ RT-PCR and Western blotting analysis indicated that the pretreatment of HTS inhibited the expression of ICAM-1 in livers after reperfusion. ⑤ Moderate hepatocyte swelling and few neutrophil infiltration were observed in HTS group.CONCLUSION: Pretreatment with HTS has the effect on hepatic ischemia reperfusion injury by inhibiting the expression of Mac-1 on circulating neutrophils and the expression of ICAM-1 in the liver.
Keywords:CD11b/CD18
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号